The enclosed article published by NPS discusses the new drug Pasireotide Diaspartate for Cushings Disease. ‘Cushing’s disease is caused by pituitary adenomas which secrete adrenocorticotrophic hormone (ACTH). Surgical treatment helps most patients, but some do not enter remission and others relapse. Pasireotide is an option for these patients and is also indicated for those who cannot have surgery. Pasireotide is given by subcutaneous injection preferably into the abdomen or top of the thigh. ‘
Why do we exist?
The Nursing CPD Institute (previously known as the Nurses Nurses Network) was created by Nurses, for Nurses.
We exist to help our Nursing colleagues to meet their Continuing Professional Development (CPD) annual registration standard requirement, with the Nursing and Midwifery Board of Australia.
We specialise in gathering information about Nursing and Health Care from a variety of sources to present CPD, both On-Line via our website and On-Tour on our Travel CPD events.